Neutralization of inhibitory antibodies and restoration of therapeutic ADAMTS‐13 activity levels in inhibitor‐treated rats by the use of defined doses of recombinant ADAMTS‐13

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|11|2053-2062

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.11, 2015-11, pp. : 2053-2062

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 936-944

John Wiley & Sons Inc

Access to resources Recommend Favorite

Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-04 ,pp. : 196-199

Karger

Access to resources Recommend Favorite

ADAMTS13 in Health and Disease

By  

Acta Haematologica, Vol. 121, Iss. 2-3, 2009-06 ,pp. : 183-185

Karger

Access to resources Recommend Favorite

ADAMTS-13 Antigen and Activity Levels in Thrombocytopenic Disorders Including Thrombotic Thrombocytopenic Purpura in Kuwait

By  

Acta Haematologica, Vol. 125, Iss. 3, 2010-12 ,pp. : 160-166

Karger

Access to resources Recommend Favorite

Presence of ADAMTS13 Activity in a Patient with Metastatic Cancer and Thrombotic Microangiopathy

By  

Acta Haematologica, Vol. 109, Iss. 3, 2003-05 ,pp. : 150-152

Karger

Access to resources Recommend Favorite